.jpg?itok=LooO274g)
Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Case Based Panel Discussion - Stage 3 NSCLC - Immunotherapy Combos Checkmate 227 a Treatment Option?
Image
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.
Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.
Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma, which are rare tumors of the mediastinum. He is an Assistant Clinical Professor of Medicine at UCSF.
Recently the doctors sat down to discuss a series of case-based scenarios. In this video, the doctors discuss the Checkmate 227 trial's suggestion of an immunotherapy combination of Yervoy (Ipilimumab) and Opdivo (Nivolumab) as another treatment option.
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Video
En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el mejor tratamiento en general.
To watch the complete playlist, click here.
Special thanks to Genentech, BMS, Takeda, Johnson & Johnson, and Daiichi-Sankyo for their sponsorship of this program.
Article
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.
Image
 (1280 x 350 px) (1280 x 250 px).png)
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Online Community
Recent Comments
The information you share is…
By LibbieRohan on
Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.
Since your doctor didn't seem too worried...